Adult-Type Diffuse Glioma — Trials

Adult-Type Diffuse Glioma — Trials · CancerIndex

Clinical trials

Registered studies

1,869 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 510
Recruiting: 273
Ph III recruiting: 18
Growth YoY: +40.7%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (296)

clinicaltrialsPublishedShowing 51–100 of 780 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07762716	Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy	not yet recruiting	Phase 1 / Phase 2	10	BreakBio CorpINDUSTRY	1	Aug 19, 2026	clinicaltrials
NCT06319027	Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial(GABLE)	recruiting	Phase 2	100	ECOG-ACRIN Cancer Research GroupNETWORK	1